Cite
Intervention with the hypoxic tumor cell sensitizer etanidazole in the combined modality treatment of limited stage small-cell lung cancer. A one-institution study.
MLA
Urtasun, R. C., et al. “Intervention with the Hypoxic Tumor Cell Sensitizer Etanidazole in the Combined Modality Treatment of Limited Stage Small-Cell Lung Cancer. A One-Institution Study.” International Journal of Radiation Oncology, Biology, Physics, vol. 40, no. 2, Jan. 1998, pp. 337–42. EBSCOhost, https://doi.org/10.1016/s0360-3016(97)00771-2.
APA
Urtasun, R. C., Palmer, M., Kinney, B., Belch, A., Hewitt, J., & Hanson, J. (1998). Intervention with the hypoxic tumor cell sensitizer etanidazole in the combined modality treatment of limited stage small-cell lung cancer. A one-institution study. International Journal of Radiation Oncology, Biology, Physics, 40(2), 337–342. https://doi.org/10.1016/s0360-3016(97)00771-2
Chicago
Urtasun, R C, M Palmer, B Kinney, A Belch, J Hewitt, and J Hanson. 1998. “Intervention with the Hypoxic Tumor Cell Sensitizer Etanidazole in the Combined Modality Treatment of Limited Stage Small-Cell Lung Cancer. A One-Institution Study.” International Journal of Radiation Oncology, Biology, Physics 40 (2): 337–42. doi:10.1016/s0360-3016(97)00771-2.